Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.57 USD | +0.03% | +0.37% | +8.60% |
05-16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
05-16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
End-of-day quotes
Sector Medical Devices & Implants
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.45B | - | |||||
127B | ||||||
11.34B | ||||||
9.11B | ||||||
5.53B | - | |||||
2.87B | - |
- Stock Market
- Equities
- AXNX Stock
- Charts Axonics, Inc.
- Sector Chart